Summit Creek Advisors LLC Has $16.93 Million Stock Position in HealthEquity, Inc. $HQY

Summit Creek Advisors LLC decreased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 184,841 shares of the company’s stock after selling 7,684 shares during the period. HealthEquity comprises about 2.7% of Summit Creek Advisors LLC’s holdings, making the stock its 6th largest holding. Summit Creek Advisors LLC owned about 0.22% of HealthEquity worth $16,933,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Xponance Inc. lifted its stake in HealthEquity by 0.8% in the 3rd quarter. Xponance Inc. now owns 12,265 shares of the company’s stock valued at $1,162,000 after purchasing an additional 102 shares during the last quarter. Truist Financial Corp lifted its stake in HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after purchasing an additional 119 shares during the last quarter. Fiduciary Trust Co increased its position in HealthEquity by 3.4% in the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after acquiring an additional 120 shares during the period. Larson Financial Group LLC increased its position in HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares during the period. Finally, GAMMA Investing LLC increased its position in HealthEquity by 9.5% in the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after acquiring an additional 168 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 3.4%

HQY opened at $87.55 on Thursday. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $116.65. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. The company has a fifty day moving average of $82.13 and a 200-day moving average of $87.03. The stock has a market cap of $7.34 billion, a PE ratio of 35.59, a price-to-earnings-growth ratio of 1.54 and a beta of 0.19.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm’s revenue was up 7.3% compared to the same quarter last year. On average, sell-side analysts predict that HealthEquity, Inc. will post 3.84 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have issued reports on HQY shares. Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Royal Bank Of Canada lowered their price objective on HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. Raymond James Financial set a $100.00 target price on HealthEquity in a report on Tuesday, February 17th. Finally, BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and upped their target price for the company from $85.00 to $105.00 in a report on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $111.79.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.